Global (United States, European Union and China) Animal Biotechnology Market Research Report 2019-2025

Animal biotechnology refers to the branch of biotechnology, which deals with the molecular biology techniques for producing genetically engineered animals (whose genome are modified), in order to make them suitable for pharmaceutical, industrial or agricultural applications. The genetically modified animals have improved growth rates, synthesized therapeutic proteins, and are resistant to various diseases. Increasing R&D by the major market players, rising regulatory approvals, and the rising focus toward cloning and transgenic animals are contributing to the market growth. However, high cost of research and development, and the ethical issues associated with animal biotechnology products may adversely affect the market growth.
In 2019, the market size of Animal Biotechnology is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Animal Biotechnology.

This report studies the global market size of Animal Biotechnology, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Animal Biotechnology sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Bayer AG
Merck &, Inc.
Pfizer, Inc.
Biogenesis Bago
Santa Cruz Biotechnology, Inc.
Boehringer Inghlem
Virbac Inc.

Market Segment by Product Type
Diagnostic Tests
Reporductive & Genetic Produtcs

Market Segment by Application
Preventive Care for Animals
Development of Animal Pharmaceuticals
Food Safety and Drug Development

Key Regions split in this report: breakdown data for each region.
United States
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Animal Biotechnology status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Animal Biotechnology manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Animal Biotechnology are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025